UniProt P04591
Gag (P04591)
Gag (UniProt P04591): 30 experimental structures on GenesisL1, 6 ligands bound, 99 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.
- UniProt
- P04591
- Protein
- Gag
- Experimental structures
- 30
- Predicted models
- 0
- Ligands
- 6
- Pockets
- 99 · 9 records with a druggable one
Structures
30 records of P04591 in the MolNFT archive: 30 experimental, 0 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 1E6J | Crystal structure of HIV-1 capsid protein (p24) in complex with Fab13B5 | x-ray diffraction | P | — | — |
| 1E6J | Crystal structure of HIV-1 capsid protein (P24) in complex with FAB13B5 | x-ray diffraction | P | — | — |
| 1TSQ | Crystal structure of AP2V substrate variant of nc-P1 decamer peptide in complex with V82A/D25N… | x-ray diffraction | P | — | — |
| 1TSQ | Crystal structure of AP2V substrate variant of nc-P1 decamer peptide in complex with V82A/D25N… | x-ray diffraction | P | — | — |
| 1TSU | Crystal structure of decamer NCP1 substrate peptide in complex with wild-type D25N HIV-1 protease… | x-ray diffraction | P | — | — |
| 1TSU | Crystal structure of decamer NCP1 substrate peptide in complex with wild-type D25N HIV-1 protease… | x-ray diffraction | P | — | — |
| 5I1R | Quantitative characterization of configurational space sampled by HIV- 1 nucleocapsid using… | solution nmr; solution scattering | A | — | — |
| 6CPL | Crystal structure of DR11 presenting the gag293 epitope | x-ray diffraction | C | NA | — |
| 6CPL | Crystal structure of DR11 presenting the GAG293 epitope | x-ray diffraction | C | NA | — |
| 6CPN | Crystal structure of DR11 presenting the RQ13 peptide | x-ray diffraction | C | SO4, NA | — |
| 6CPO | Crystal structure of DR15 presenting the RQ13 peptide | x-ray diffraction | C, F | — | 2 (best 0.51) |
| 6CPO | Crystal structure of DR15 presenting the RQ13 peptide | x-ray diffraction | C, F | — | — |
| 6CQJ | Crystal structure of DR1 presenting the RQ13 peptide | x-ray diffraction | C, F, I | — | 4 (best 0.73) |
| 6CQJ | Crystal structure of DR1 presenting the RQ13 peptide | x-ray diffraction | C, F, I | — | — |
| 6CQL | Crystal structure of F24 TCR -DR11-RQ13 peptide complex | x-ray diffraction | C | — | — |
| 6CQL | Crystal structure of F24 TCR -DR11-RQ13 peptide complex | x-ray diffraction | C | — | — |
| 6CQN | Crystal structure of F5 TCR -DR11-RQ13 peptide complex | x-ray diffraction | C | MG | — |
| 6CQQ | Crystal structure of F24 TCR -DR15-RQ13 peptide complex | x-ray diffraction | C, H | MG | — |
| 6CQQ | Crystal structure of F24 TCR -DR15-RQ13 peptide complex | x-ray diffraction | C, H | MG | — |
| 6CQR | Crystal structure of F24 TCR -DR1-RQ13 peptide complex | x-ray diffraction | C, H | — | 5 (best 0.75) |
| 6CQR | Crystal structure of F24 TCR -DR1-RQ13 peptide complex | x-ray diffraction | C, H | — | — |
| 6EC2 | Structure of HIV-1 CA 1/3-hexamer | x-ray diffraction | A, C, F, G | — | 9 (best 0.72) |
| 6EC2 | Structure of HIV-1 ca 1/3-hexamer | x-ray diffraction | A, C, F, G | — | — |
| 6ECN | HIV-1 CA 1/2-hexamer-EE | x-ray diffraction | A, B, D, E | — | 15 (best 0.72) |
| 6ECN | HIV-1 ca 1/2-hexamer-ee | x-ray diffraction | A, B, D, E | — | — |
| 6ECO | Hexamer-2-Foldon HIV-1 capsid platform | x-ray diffraction | A, D | — | 4 (best 0.79) |
| 6ECO | Hexamer-2-foldon HIV-1 capsid platform | x-ray diffraction | A, D | — | — |
| 9CWV | Gag CA-SP1 immature lattice from intact enveloped virus-like particles | electron microscopy | A, C, B, D, E, F, G, H, I, J, K, L, M, N, O, P, Q, R | IHP | 20 (best 0.84) |
| 9D6C | Gag CA-SP1 immature lattice bound with Lenacapavir and Bevirimat from enveloped virus like particles | electron microscopy | A, B, C, D, E, F, G, H, I, J, K, L, M, N, O, P, Q, R | QNG, 2I4, IHP | 20 (best 0.85) |
| 9DWD | Gag CA-SP1 immature lattice bound with Lenacapavir from enveloped virus like particles (T8I) | electron microscopy | A, B, C, D, E, F, G, H, I, J, K, L, M, N, O, P, Q, R | QNG, IHP | 20 (best 0.84) |
Ligands
- IHP · Inositol hexakisphosphate · in 3 records
- MG · Magnesium ion · in 3 records
- NA · Sodium ion · in 3 records
- QNG · N-[(1S)-1-(3-{4-chloro-3-[(methylsulfonyl)amino]-1-(2, 2,2-trifluoroethyl)-1H-indazol-7-yl}-6-[3-methyl-3-(methylsulfonyl)but-1-yn-1-yl]pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl]-2-[(3bs,4ar)-5,5-difluoro-3-(trifluoromethyl)-3B,4,4A,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl]acetamide · in 2 records
- 2I4 · 3alpha-[(3-carboxy-3-methylbutanoyl)oxy]-8alpha,9beta,10alpha,13alpha,17alpha,19beta-lup-20(29)-en-28-oic acid · in 1 record
- SO4 · Sulfate ion · in 1 record
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.